Neurovirulence of yellow fever 17DD vaccine virus to rhesus monkeys
- 29 October 2003
- Vol. 316 (1) , 55-63
- https://doi.org/10.1016/s0042-6822(03)00583-x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Viremia and Immunogenicity in Nonhuman Primates of a Tetravalent Yellow Fever–Dengue Chimeric Vaccine: Genetic Reconstructions, Dose Adjustment, and Antibody Responses against Wild-type Dengue Virus IsolatesVirology, 2002
- Phenotypic and Molecular Analyses of Yellow Fever 17DD Vaccine Viruses Associated with Serious Adverse Events in BrazilVirology, 2001
- Hepatitis and death following vaccination with 17D-204 yellow fever vaccineThe Lancet, 2001
- Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four casesThe Lancet, 2001
- Recombinant Chimeric Yellow Fever-Dengue Type 2 Virus Is Immunogenic and Protective in Nonhuman PrimatesJournal of Virology, 2000
- Genetic variability among yellow fever virus 17D substrainsVaccine, 1998
- Phenotypic Analysis of Yellow Fever Virus Derived from Complementary DNAThe American Journal of Tropical Medicine and Hygiene, 1995
- The monkey safety test for neurovirulence of yellow fever vaccines: the utility of quantitative clinical evaluation and histological examinationJournal of Biological Standardization, 1987
- Ontogeny of Yellow Fever 17D Vaccine: RNA Oligonucleotide Fingerprint and Monoclonal Antibody Analyses of Vaccines Produced World-wideJournal of General Virology, 1983
- Pathophysiologic Correlations in a Rhesus Monkey Model of Yellow FeverThe American Journal of Tropical Medicine and Hygiene, 1981